(EUN2) iShares II Public - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE0008471009
EUN2: Exchange-Traded Fund, Eurozone, Large-Cap, Equity, Index
The iShares II Public Limited Company - iShares EURO STOXX50 UCITS ETF (XETRA:EUN2) is an exchange-traded fund that tracks the Morningstar Dev Ezn TME NR EUR Index, providing investors with exposure to the Eurozones largest and most liquid stocks. With its primary listing on the XETRA exchange, this ETF is designed for investors seeking to capitalize on the performance of the Eurozones blue-chip companies.
The funds investment objective is to replicate the performance of its underlying index, which comprises the top 50 stocks in the Eurozone. By doing so, it offers a diversified portfolio with a bias towards large-cap companies, potentially reducing the risk associated with individual stock selection. As a UCITS-compliant ETF, it adheres to strict regulatory guidelines, ensuring a certain level of investor protection.
Analyzing the ETFs recent price action, we observe a bullish trend, with the short-term Simple Moving Average (SMA20) at €55.46 and the long-term SMA200 at €51.38, indicating a positive momentum. The Average True Range (ATR) of 0.61, equivalent to 1.09%, suggests relatively moderate volatility. Given the current price of €55.71, we can anticipate a potential continuation of the uptrend, driven by the Eurozones large-cap stocks.
Using historical data and fundamental analysis, we forecast that the iShares EURO STOXX50 UCITS ETF will continue to perform in line with the Eurozones largest companies. With Assets Under Management (AUM) standing at €3749.24 million, the fund benefits from economies of scale, potentially reducing costs for investors. Our forecast suggests that the ETF may reach €58.50 in the next 6-12 months, driven by a combination of positive technical indicators and a favorable fundamental outlook for the Eurozones blue-chip companies.
To validate this forecast, we will continue to monitor the ETFs technical and fundamental data, adjusting our projections accordingly. By combining rigorous analysis with a commitment to intellectual honesty, we aim to provide actionable insights for investors seeking to capitalize on the opportunities presented by the iShares EURO STOXX50 UCITS ETF.
Additional Sources for EUN2 ETF
EUN2 ETF Overview
Market Cap in USD | 4,326m |
Category | Eurozone Large-Cap Equity |
TER | 0.10% |
IPO / Inception | 2000-04-03 |
EUN2 ETF Ratings
Growth Rating | 76.9 |
Fundamental | - |
Dividend Rating | 60.5 |
Rel. Strength | -1.05 |
Analysts | - |
Fair Price Momentum | 56.01 EUR |
Fair Price DCF | - |
EUN2 Dividends
Dividend Yield 12m | 2.60% |
Yield on Cost 5y | 4.87% |
Annual Growth 5y | 13.94% |
Payout Consistency | 94.9% |
Payout Ratio | % |
EUN2 Growth Ratios
Growth Correlation 3m | 51.9% |
Growth Correlation 12m | 71.9% |
Growth Correlation 5y | 91% |
CAGR 5y | 14.05% |
CAGR/Max DD 5y | 0.60 |
Sharpe Ratio 12m | 1.27 |
Alpha | 2.06 |
Beta | 0.601 |
Volatility | 11.22% |
Current Volume | 84.2k |
Average Volume 20d | 36.7k |
As of June 16, 2025, the stock is trading at EUR 54.36 with a total of 84,245 shares traded.
Over the past week, the price has changed by -2.42%, over one month by -1.81%, over three months by -1.00% and over the past year by +11.41%.
Yes. Based on ValueRay´s Analyses, iShares II Public (XETRA:EUN2) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 76.88 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EUN2 is around 56.01 EUR . This means that EUN2 is currently overvalued and has a potential downside of 3.04%.
iShares II Public has no consensus analysts rating.
According to our own proprietary Forecast Model, EUN2 iShares II Public will be worth about 62.4 in June 2026. The stock is currently trading at 54.36. This means that the stock has a potential upside of +14.85%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 62.4 | 14.8% |